跳至主要内容
临床试验/EUCTR2010-018303-28-FR
EUCTR2010-018303-28-FR进行中(未招募)不适用

Etude pilote des signes électro-encéphalographiques de réveil secondaire à l’injection de sugammadex : évaluation par l’enregistrement de l’Index Bispectral et du NeuroSENSE (étude prospective, randomisée, monocentrique et réalisée en double aveugle) - Suggamadex-Réveil

Hopital Foch0 个研究点开始时间: 2010年3月16日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Hopital Foch

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients scheduled for general anesthesia
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Age under 18 years
  • - Pregnancy, non menopausal woman
  • - Allergy to propofol, soybeans or peanuts
  • - Allergy to sufentanil, remifentanil, morphine, or to a component
  • - Hypersensibility to sufentanil, remifentanil or to a derivate of fentanyl
  • - Allergy to rocuronium or to bromure ion
  • - History of a central neurological disorder or of a lesion cerebral
  • - Patients receiving a psychotropic treatment
  • - Presence of a pace-maker
  • - Hypersensibility to sugammadex or to a component
  • - Preoperative or immediate postoperative treatment with toremifene, flucloxacilline, or fusidic acid

研究者

发起方
Hopital Foch

相似试验